Validation and characterization of a novel method for selective vagal deafferentation of the gut
- 1 October 2017
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 313 (4) , G342-G352
Abstract
There is a lack of tools that selectively target vagal afferent neurons (VAN) innervating the gut. We use saporin (SAP), a potent neurotoxin, conjugated to the gastronintestinal (GI) hormone cholecystokinin (CCK-SAP) injected into the nodose ganglia (NG) of male Wistar rats to specifically ablate GI‐VAN. We report that CCK-SAP ablates a subpopulation of VAN in culture. In vivo, CCK-SAP injection into the NG reduces VAN innervating the mucosal and muscular layers of the stomach and small intestine but not the colon, while leaving vagal efferent neurons intact. CCK-SAP abolishes feeding-induced c-Fos in the NTS, as well as satiation by CCK or glucagon like peptide-1 (GLP-1). CCK-SAP in the NG of mice also abolishes CCK-induced satiation. Therefore, we provide multiple lines of evidence that injection of CCK-SAP in NG is a novel selective vagal deafferentation technique of the upper GI tract that works in multiple vertebrate models. This method provides improved tissue specificity and superior separation of afferent and efferent signaling compared with vagotomy, capsaicin, and subdiaphragmatic deafferentation. NEW & NOTEWORTHY We develop a new method that allows targeted lesioning of vagal afferent neurons that innervate the upper GI tract while sparing vagal efferent neurons. This reliable approach provides superior tissue specificity and selectivity for vagal afferent over efferent targeting than traditional approaches. It can be used to address questions about the role of gut to brain signaling in physiological and pathophysiological conditions.Keywords
Funding Information
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (R00DK094871, R21DK110511)
This publication has 50 references indexed in Scilit:
- Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerveProceedings of the National Academy of Sciences of the United States of America, 2011
- Plasticity of nodose ganglion neurons after capsaicin- and vagotomy-induced nerve damage in adult ratsNeuroscience, 2010
- Neuropathic pain is maintained by brainstem neurons co-expressing opioid and cholecystokinin receptorsBrain, 2008
- Cholecystokinin Regulates Expression of Y2 Receptors in Vagal Afferent Neurons Serving the StomachJournal of Neuroscience, 2008
- The vagus nerve, food intake and obesityRegulatory Peptides, 2008
- Leptin and CCK modulate complementary background conductances to depolarize cultured nodose neuronsAmerican Journal of Physiology-Cell Physiology, 2006
- Expression of Cannabinoid CB1 Receptors by Vagal Afferent Neurons Is Inhibited by CholecystokininJournal of Neuroscience, 2004
- The Unusual Stability of Saporin, a Candidate for the Synthesis of ImmunotoxinsBiochemical and Biophysical Research Communications, 1997
- Characterization of type A and type B CCK receptor binding sites in rat vagus nerveBrain Research, 1993
- Effects of cholecystokinin (CCK-8) on two classes of gastroduodenal vagal afferent fibreJournal of the Autonomic Nervous System, 1990